IRE1α deficiency promotes tumor cell death and eIF2α degradation through PERK dipendent autophagy

Area of Science:

• Cellular Biology
• Molecular Biology
• Biochemistry

Background:

• Endoplasmic reticulum (ER) stress is a cellular state that occurs when the ER's folding capacity is overwhelmed.
• IRE1α and PERK are key sensors of ER stress, playing crucial roles in cellular response and survival.
• The interplay between IRE1α and PERK pathways in ER stress remains incompletely understood.

Purpose of the Study:

• To investigate the relationship between the IRE1α and PERK pathways in the context of ER stress.
• To determine the impact of IRE1α deficiency on cell survival and eIF2α expression under ER stress.
• To elucidate the mechanisms underlying eIF2α regulation and cell death in response to ER stress.

Main Methods:

• Utilized U937 and BC3 cell lines, exposing them to subcytotoxic concentrations of Tunicamycin.
• Employing pharmacological inhibition (4μ8C, GSK2606414, CA074) and genetic manipulation (siRNA) to target IRE1α and PERK pathways.
• Assessed cell viability, eIF2α expression, and autophagy flux using specific inhibitors (bafilomycin) and proteasome inhibition.

Main Results:

• IRE1α deficiency, whether pharmacological or genetic, led to decreased eIF2α expression and increased cell death in ER-stressed cells.
• Inhibition of PERK (GSK2606414 or siRNA) prevented eIF2α down-regulation and restored cell survival.
• eIF2α degradation was mediated by autophagy, dependent on PERK activation and Cathepsin B activity, but not proteasomal degradation.

Conclusions:

• IRE1α deficiency triggers an unexpected decrease in eIF2α levels through PERK-dependent autophagy during ER stress.
• This mechanism contributes to increased cell death, highlighting a novel regulatory axis.
• Targeting IRE1/XBP1 may be a viable cancer therapy, whereas PERK inhibitors might counteract this effect.